1. Home
  2. QLGN vs JTAI Comparison

QLGN vs JTAI Comparison

Compare QLGN & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QLGN
  • JTAI
  • Stock Information
  • Founded
  • QLGN 1996
  • JTAI 2018
  • Country
  • QLGN United States
  • JTAI United States
  • Employees
  • QLGN N/A
  • JTAI N/A
  • Industry
  • QLGN Biotechnology: Pharmaceutical Preparations
  • JTAI Blank Checks
  • Sector
  • QLGN Health Care
  • JTAI Finance
  • Exchange
  • QLGN Nasdaq
  • JTAI Nasdaq
  • Market Cap
  • QLGN 3.4M
  • JTAI 3.4M
  • IPO Year
  • QLGN N/A
  • JTAI N/A
  • Fundamental
  • Price
  • QLGN $4.18
  • JTAI $4.15
  • Analyst Decision
  • QLGN
  • JTAI
  • Analyst Count
  • QLGN 0
  • JTAI 0
  • Target Price
  • QLGN N/A
  • JTAI N/A
  • AVG Volume (30 Days)
  • QLGN 54.9K
  • JTAI 1.2M
  • Earning Date
  • QLGN 11-14-2024
  • JTAI 11-14-2024
  • Dividend Yield
  • QLGN N/A
  • JTAI N/A
  • EPS Growth
  • QLGN N/A
  • JTAI N/A
  • EPS
  • QLGN N/A
  • JTAI N/A
  • Revenue
  • QLGN N/A
  • JTAI $15,028,926.00
  • Revenue This Year
  • QLGN N/A
  • JTAI $21.49
  • Revenue Next Year
  • QLGN N/A
  • JTAI $10.05
  • P/E Ratio
  • QLGN N/A
  • JTAI N/A
  • Revenue Growth
  • QLGN N/A
  • JTAI 46.66
  • 52 Week Low
  • QLGN $3.34
  • JTAI $3.51
  • 52 Week High
  • QLGN $30.50
  • JTAI $731.25
  • Technical
  • Relative Strength Index (RSI)
  • QLGN 43.01
  • JTAI 31.95
  • Support Level
  • QLGN $3.53
  • JTAI $3.64
  • Resistance Level
  • QLGN $4.39
  • JTAI $5.10
  • Average True Range (ATR)
  • QLGN 0.33
  • JTAI 0.65
  • MACD
  • QLGN 0.06
  • JTAI 0.51
  • Stochastic Oscillator
  • QLGN 50.98
  • JTAI 18.86

About QLGN Qualigen Therapeutics Inc.

Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as via Jet Token's leased and managed aircraft.

Share on Social Networks: